TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ARGX

argenx NV

Healthcare · Biotechnology

856.90$ -2.2% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,816 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARGX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
330 758 401 902 573 1,346 791 948 1,127 3,206 1,298 2,816 8,446
36 574 43 43 59 665 81 111 109 340 121 279 850
294 184 358 425 514 681 710 837 1,018 2,866 1,177 2,536 7,597
192 397 225 447 236 297 309 328 356 443 443 486 1,728
192 199 236 341 278 257 276 423 336 423 355 533 1,646
374 797 451 451 500 563 569 633 777 2,015 904 1,690 5,385
-81 -219 -93 -139 14 117 141 204 350 851 394 847 2,442
0.2 0.3 0.5 0.6 0.7 0.7 1.1 1.1 1.0 1.0 1.0 2.0 5.0
-83 -144 -74 -89 88 175 202 287 386 992 426 959 2,763
-11 27 -13 -57 -3.4 33 33 42 -55 119
-73 -156 -62 -33 91 866 169 245 344 1,047 366 839 2,596
-83 -38 -74 -21 89 127 203 288 1,009 864

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?